FDA Drug recall D-0909-2016
SUPER HERBS 350 mg, 30 capsules per bottle
- FDA Drug
- Class I
- terminated
- Published 2016-06-01
On 2016-06-01 the FDA classified a Class I recall of SUPER HERBS 350 mg, 30 capsules per bottle by Super Herbs, citing marketed without an approved NDA/ANDA - presence of undeclared sibutramine, desmethylsibutramine (an active metabolite of sibutramine) and/or phenolphthalein.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0909-2016 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2015-11-23 |
| Published | 2016-06-01 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Super Herbs |
| Distribution | n/a |
Product
SUPER HERBS 350 mg, 30 capsules per bottle.
Reason
Marketed without an approved NDA/ANDA - presence of undeclared sibutramine, desmethylsibutramine (an active metabolite of sibutramine) and/or phenolphthalein.
Identifiers
| code_info | All lots |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0909-2016%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.